Loss of function of BRCA1/2, ATM (a DNA-damage checkpoint indirectly activating HRR), and other HRR genes are associated with more aggressive PCs (higher Gleason score; lymph node involvement, and/or metastatic disease at presentation; worse CSS/MFS) [169,170]. This evidence concerns the gene BRCA1 and metastatic neoplasm.